Here's what we'll cover
Here's what we'll cover
If you take a GLP-1 medication like Ozempic or Wegovy, you probably started for your health. What you may not have expected is landing in the middle of a much bigger cultural shift, one that now reaches clothing racks, retail earnings calls, and the way people talk about body size.
Understanding that shift can help you plan for the practical and emotional changes that often come with significant weight loss, and keep the focus where it belongs: on your health.
How Many People Are Taking GLP-1s?
Use is no longer niche. In a KFF poll fielded in late 2025, about 1 in 8 U.S. adults (12%) said they were currently taking a GLP-1 drug, and 18% said they had taken one at some point. Shopper data shows a similar picture: market research firm Circana estimated that about 23% of U.S. households were using GLP-1 medications as of September 2025, according to Retail Dive.
The weight loss behind those numbers is substantial. In the STEP 1 trial, semaglutide 2.4 mg produced about 15% average weight loss over 68 weeks. In SURMOUNT 1, tirzepatide, the active ingredient in Mounjaro and Zepbound, produced up to about 21% at the highest dose over 72 weeks.
What the Fashion Industry Is Seeing
When millions of people change size, retailers notice. Circana data reported by Retail Dive in March 2026 found:
- About 80% of GLP-1 households expect to need new clothing because their size is changing.
- About 55% had already bought new clothing or footwear mainly for that reason.
- Sales of larger bra sizes slowed while mid to smaller sizes rose, which Circana called an early sign of a possibly major shift.
- In their first year on GLP-1s, these households bought more active shorts, jeans, casual pants, bras, and dresses.
Some plus size focused retailers have reported pressure. Destination XL said it believed about 25% of its customers use GLP-1s and described size shifts and volatility in its business, while Torrid reported falling sales and store closures, according to the same report. Those results have several causes, but GLP-1 use is now part of the conversation.
The Size Inclusivity Worry
Fashion spent years under pressure to expand extended sizes. Some advocates now worry that if extended size sales slow, brands will quietly cut those ranges, leaving fewer options for people who are not on GLP-1 medications, cannot access them, or simply choose not to take them.
That concern is worth taking seriously. Body size diversity does not disappear because a medication exists, and access to these drugs is still uneven. At the same time, treating obesity as a medical condition with effective treatment, rather than a personal failing, is a meaningful shift in its own right.
What Patients Are Experiencing Personally
Many people describe shopping after major weight loss as exciting and disorienting at once. Clothes that fit for years stop fitting within months. Some sizes become available for the first time. It is common to feel unsure how to dress a changing body.
A few practical tips:
- Buy a small number of transitional basics rather than a full wardrobe while weight is still changing.
- Use tailoring for pieces you love, since alterations can extend their life through several sizes.
- Consider resale, consignment, or clothing swaps to manage cost.
- Wait until your weight has been stable for a few months before major wardrobe purchases.
Stigma Cuts Both Ways
People taking GLP-1s can face judgment from two directions. Some hear that medication is the easy way out. Others meet assumptions that weight loss was effortless. Neither view reflects the reality of managing a chronic condition.
Research on weight stigma, including a widely cited review by Puhl and Heuer in the American Journal of Public Health, shows that negative attitudes toward people with obesity are linked to worse health outcomes, including avoiding medical care. Framing obesity as a biological condition with hormonal and metabolic drivers helps reduce that harm.
Social Media, Off Label Use, and Access
GLP-1s are one of the most discussed health topics online. Open conversation has helped many people feel less alone. It has also fueled cosmetic interest from people who do not meet medical criteria, and a market for unapproved and counterfeit products. If you are prescribed a GLP-1, buy only from state licensed pharmacies and work with a licensed prescriber. You can compare vetted telehealth providers to find one with reliable pharmacy relationships.
What This Shift Means for Long Term Patients
Maintenance Is the Real Work
In the STEP 1 extension, people who stopped semaglutide regained about two thirds of the weight they had lost within a year. Cultural coverage tends to celebrate the loss and skip the maintenance. Set long term expectations with your provider.
Relationships Can Change
Significant weight loss can change how friends, partners, and coworkers relate to you, and how you see yourself. Those changes are worth talking about, with your provider or a counselor if needed.
Cost Has Fallen, but Not for Everyone
Manufacturer self pay prices have dropped sharply since 2024. Approximate prices checked in October 2026, as compiled by Kymata Health:
| Medication | Active ingredient | FDA approval | Typical self pay monthly price |
|---|---|---|---|
| Wegovy pill | Semaglutide | Chronic weight management | About $149 to $299 by dose |
| Wegovy pen | Semaglutide | Chronic weight management | About $199 for starter doses, then $349 |
| Zepbound | Tirzepatide | Chronic weight management and sleep apnea | About $299 to $449 by dose |
| Ozempic | Semaglutide | Type 2 diabetes | About $199 to $499 |
Prices change often, so check GLP-1 coupons and savings programs before you buy.
Redefining What Healthy Looks Like
GLP-1 research is also pushing the conversation past the number on the scale. In the SELECT trial, semaglutide reduced major cardiovascular events by 20% in adults with overweight or obesity and established heart disease. Outcomes like blood pressure, blood sugar, liver health, and heart risk are increasingly part of how doctors judge success.
Tracking those markers with your provider gives a fuller picture of whether treatment is working for you than appearance or clothing size ever could.
No waiting list. No insurance needed.
Frequently Asked Questions
How many Americans are taking GLP-1 drugs?
In a KFF poll fielded in late 2025, about 12% of U.S. adults said they were currently taking a GLP-1 drug and 18% said they had ever taken one.
How are GLP-1 drugs affecting the fashion industry?
Circana data reported in March 2026 found about 80% of GLP-1 households expect to need new clothing and 55% have already bought some, with early shifts toward smaller bra sizes and more active and casual wear purchases.
Will brands stop making plus sizes because of GLP-1 drugs?
There is no evidence of an industry wide exit, but some plus size focused retailers have reported sales pressure. Advocates worry that slower extended size sales could lead brands to cut ranges.
When should I buy new clothes while losing weight on a GLP-1?
Buy a few transitional basics while your weight is changing, use tailoring and resale, and wait until your weight has been stable for a few months before larger purchases.
Do GLP-1 drugs change how people treat you?
Many patients report changes in how friends, partners, and coworkers relate to them, along with shifts in self image. Talking with your provider or a counselor can help.
What happens if I stop my GLP-1 after losing weight?
In the STEP 1 extension, people who stopped semaglutide regained about two thirds of their lost weight within a year, so maintenance plans matter.
The Bottom Line
GLP-1 medications are changing more than individual bodies. With about 1 in 8 adults currently taking one, retailers are seeing real shifts in sizing and wardrobe demand, and the cultural conversation about weight is changing with them.
For you as a patient, the practical lessons are simple: keep your goals focused on health markers, plan for wardrobe and social changes, think about maintenance from the start, and remember that treating a medical condition is a medical decision, not a cultural statement. To find a prescriber who takes your full health picture seriously, compare vetted telehealth providers. Always consult your physician before starting, changing, or stopping any medication.